The relationship of agonist efficacy to the rate of G protein‐coupled receptor signaling desensitization is controversial. Expressing inwardly rectifying potassium channels (GIRKs) in Xenopus oocytes, we have devised a signaling assay that clearly identifies CB1 cannabinoid receptor agonists with low intrinsic efficacy. In this assay, the synthetic CB1 agonists, AM411, AM782, AM1902, AM2233 and WIN55,212‐2 and the endogenous cannabinoid, 2‐arachidonoyl ester, were full agonists. The synthetic CB1 agonist AM356 (methanandamide), the endogenous cannabinoids, anandamide and 2‐arachidonoyl ether, and the phytocannabinoid, Δ9THC, were partial agonists. The rate of desensitization of CB1 was independent of agonist efficacy. WIN55,212‐2, AM782, AM1902, AM2233, and 2‐arachidonoyl glycerol ester all desensitized quickly, with desensitization rates varying from 14% min−1 to 10% min−1. AM356, AM411, anandamide, and Δ9THC all desensitized considerably slower, at a rate of 5% min−1. Despite high potency and efficacy, AM411 desensitized as slowly as anandamide and Δ9THC. CB1 agonist efficacy and rate of desensitization are not necessarily related. British Journal of Pharmacology (2004) 142, 495–500. doi:10.1038/sj.bjp.0705792
British Journal of Pharmacology – Wiley
Published: Jun 1, 2004
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera